跳至主要内容
临床试验/NCT00931996
NCT00931996终止不适用

Clinical and Computational Studies of Dopamine Function in Schizophrenia

University of Illinois at Chicago1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
12
试验地点
1
主要终点
Positive and Negative Syndrome Scale (PANSS) Score Change From Baseline.

研究概览

简要总结

DESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia. However, the regional disturbances in brain function causing these deficits are not yet known. This application proposes a series of integrated behavioral studies designed to identify causes of deficits in schizophrenia.

详细描述

We will be assessing clinical symptoms and cognition before and after treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
15 Years 至 64 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion Criteria: Inclusion criteria for this study are (1) able and willing to give written informed consent; (2) no contraindications to MRI (cardiac pacemaker, aneurysm clip, cochlear implants, IUD, shrapnel, history of metal fragments in eyes, neurostimulators or other metal devices, weight of 250lbs or more, claustrophobia) and (3) medically stable. Sedation will not be used for MRI studies because cooperation is essential.

排除标准

  • Any subject is excluded from the imaging studies if they have any contraindications to MRI such as cardiac pacemaker, aneurysm clip, cochlear implants, pregnancy in the later stages (because of body size and limited comfort for MRI studies), IUD, shrapnel, history of metal fragments in eyes, neurostimulators, weight of 250 lbs. or more, or claustrophobia. Individuals with mental retardation, neurologic disease or significant medical illness that might effect neuronal or vascular physiology will not be recruited.

研究组 & 干预措施

Antipsychotic

Experimental

Antipsychotic

干预措施: Antipsychotic (Drug)

结局指标

主要结局

Positive and Negative Syndrome Scale (PANSS) Score Change From Baseline.

时间窗: Baseline and 6 weeks

Positive and Negative Syndrome Scale (PANSS) Total Score. 1 to 7 on 30 different symptoms based on the interview as well as reports of family members or primary care hospital workers. PANSS Total score minimum = 30, maximum = 210 Higher scores represent more severe symptoms. A positive change score (baseline-6 weeks) indicates an improvement in symptoms.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey R. Bishop

Assistant Professor

University of Illinois at Chicago

研究点 (1)

Loading locations...

相似试验

Oculomotor and Spatial Cognition Deficits in... | 临床试验